Founded
2018
Web
Sign in to see organisation website
Address
BEAVERTON
Unified Communication Framework Unified Communication Framework Enabler of CoDesign About UCF ADDITIONAL INFORMATION Copyright 2025 Unified Communication Framework. All rights reserved. UCF Alliance Administration co VTM Inc. 3855 SW 153rd Drive Beaverton OR 97003 USA.
From Social media
News about from their social media (Facebook and X).
Data about organisation
BEAVERTON
Organisations from UNIFIED COMMUNICATION FRAMEWORK

1. Westside United Methodist Church
The United Methodist Church is a worldwide connection of close to 10 million members in over 100 countries including Africa, Asia, Europe and the United States.

3. Washington County Visitors Association
Scenically situated between Portland and the Oregon Coast, Oregon's Tualatin Valley is the gateway to wine country and is home to a multitude of things to see and do.

4. WASHINGTON COUNTY 4-H OREOGN
This is the official Facebook page of Oregon State University.

5. National Network of Abortion Funds
The National Network of Abortion Funds is a network of orgs that are funding abortion& building power.
Similar organisations
Similar organisations to UNIFIED COMMUNICATION FRAMEWORK based on mission, location, activites.
More Similar OrganisationsSimilar Organisations Worldwide
Organisations in the world similar to UNIFIED COMMUNICATION FRAMEWORK.

CANADIAN CONSTITUTION FOUNDATION (ca)
The Canadian Constitution Foundation is "Freedom's Defence Team".

Mission Aviation Fellowship Australia is a Christian organisation whose mission is to serve together to bring help, hope, and healing through aviation.

CARF International is an independent, nonprofit accreditor of health and human services.
Interesting nearby
Interesting organisations close by to residence of UNIFIED COMMUNICATION FRAMEWORK
More Interesting nearbyJoin us and make a difference for the future!
Sign Up
Please fill in your information. Everything is free, we might contact you with updates (but cancel any time!)
Sign in with GoogleOr
Good News

Exciting news! 🎉 ADARx Pharmaceuticals has just dosed the first participant in a Phase III trial for ADX-324, a promising treatment for hereditary angioedema! This innovative therapy shows great potential in improving lives. Let’s celebrate advancements in healthcare! #GoodNews #HealthcareInnovation
ADARx doses first subject in Phase III trial of ADX-324 for HAE
Yahoo
Like Comment